Q9Y233 (PDE10_HUMAN) Homo sapiens (Human)

cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A UniProtKBInterProSTRINGInteractive Modelling

1055 aa; Sequence (Fasta) ; (Isoform 1; Isoform 2)

Available Structures

355 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Crystal Structure of PDE10A with a biaryl ether inhibitor ((1-(3-(4-((1H-benzo[d]imidazol-2-yl)amin…homo-3-mer718-1035
ZN; 18×SO4;15J;
Assess
Crystal Structure of PDE10A with a biaryl ether inhibitor (1-(1-(3-(4-(benzo[d]thiazol-2-ylamino)ph…homo-3-mer718-1035
ZN; 24×SO4;GOL;15H;
Assess
PDE10a Crystal Structure Complexed with Novel Inhibitorhomo-3-mer718-1035
ZN; 21×SO4;0JQ;
Assess
Crystal Structure of PDE10A with Imidazo[4,5-b]pyridines as Potent and Selective Inhibitorshomo-3-mer718-1035
ZN; 36×SO4; 15×GOL;2KR;
Assess
Crystal structure of PDE10a with a novel Imidazo[4,5-b]pyridine inhibitorhomo-3-mer729-1035
1IS;1IR;ZN;SO4;GOL;
Assess
2-(3-alkoxy-1-azetidinyl) quinolines as novel PDE10A inhibitorshomo-3-mer729-1033
ZN; 21×SO4;GOL;35D;
Assess
Crystal structure of 2-(3-alkoxy-1-azetidinyl) quinolines as PDE10A Inhibitorshomo-3-mer730-1032
21×SO4;GOL;35E;ZN;
Assess
Identification and structural characterization of PDE10 fragment inhibitorshomo-2-mer715-1040
ZN;MG;F03;
Assess
2-[2-(4-Phenyl-1H-imidazol-2-yl)ethyl]quinoxaline (Sunovion Compound 14) co-crystallized with PDE10Ahomo-2-mer715-1035
ZN;MG;4F7;
Assess
PDE10 complexed with 4-isopropoxy-2-(2-(3-(4-methoxyphenyl)-4-oxo-3,4-dihydroquinazolin-2-yl)ethyl)…homo-2-mer715-1035
ZN;MG;4PX;4Q0;
Assess
Co-crystal structure of 2-[2-(5,8-dimethyl[1,2,4]triazolo[1,5-a]pyrazin-2-yl)ethyl]-3-methyl-3H-imi…homo-2-mer715-1035
ZN;MG;4GK;
Assess
Crystal Structure of PDE10A with Novel Keto-Benzimidazole Inhibitorhomo-2-mer718-1035
ZN; 15×SO4;GOL;2F4;
Assess
Crystal structure of the catalytic domain of PDE10A complexed with 1-(2-fluoro-4-(1H-pyrazol-1-yl)p…homo-2-mer721-1035
MG;ZN;3K9;
Assess
Crystal structure of the catalytic domain of PDE10A complexed with 3-(1-phenyl-1H-pyrazol-5-yl)-1-(…homo-2-mer721-1035
MG;ZN;3KG;
Assess
Crystal Structure of PDE10A with Novel Keto-Benzimidazole Inhibitorhomo-2-mer728-1035
ZN; 12×SO4;2F5;
Assess
Crystal Structure of PDE10A with 1H-benzimidazol-2-yl(4-((3-(tetrahydro-2H-pyran-4-yl)-2-pyridinyl)…homo-2-mer730-1034
ZN;SO4;2W1;
Assess
Crystal structure of the C-terminal GAF domain of human phosphodiesterase 10Ahomo-2-mer522-698
CMP;
Assess
Crystal structure of PDE10A2 with fragment ZT450monomer715-1043
7ZE;NI;
Assess
Crystal structure of PDE10A2 with fragment ZT464monomer715-1042
9ZE;NI;EDO;
Assess
crystal structure of pde10a2 mutant D564A in complex with cAMP.monomer715-1042
ZN;MG;CMP;
Assess
Crystal structure of PDE10A2 with fragment ZT902monomer715-1041
JPZ;NI;
Assess
Crystal structure of PDE10A2 with fragment ZT462monomer715-1041
8ZE;NI;
Assess
Crystal structure of PDE10A2 with fragment ZT217monomer715-1041
MEW;NI;
Assess
Crystal structure of PDE10A2 with fragment ZT214monomer715-1041
1XN;NI;
Assess
Crystal structure of PDE10A2 with fragment ZT0429 (4-methyl-3-nitropyridin-2-amine)monomer715-1041
2ZV;NI;
Assess
Crystal structure of PDE10A2 with fragment ZT017monomer715-1041
1XM;NI;
Assess
Crystal structure of PDE10A2 with fragment ZT0449 (5-nitro-1H-benzimidazole)monomer715-1041
2ZM;NI;
Assess
Crystal structure of PDE10A2 with fragment ZT448monomer715-1041
5NI;NI;
Assess
Crystal structure of PDE10A2 with fragment ZT434monomer715-1041
5ZE;NI;
Assess
Crystal structure of PDE10A2 with fragment ZT401monomer715-1041
4ZE;NI;
Assess
Crystal structure of PDE10A2 with fragment ZT0443 (6-chloropyrimidine-2,4-diamine)monomer715-1041
2ZX;NI;
Assess
Crystal structure of PDE10A2 with fragment ZT0120 (7-chloroquinolin-4-ol)monomer715-1041
MRW;NI;
Assess
Crystal structure of PDE10A2 with fragment ZT0451 (8-nitroquinoline)monomer715-1041
2ZQ;NI;
Assess
Crystal structure of PDE10A2 with fragment ZT1595 (2-[(quinolin-7-yloxy)methyl]quinoline)monomer715-1041
2ZT;NI;
Assess
Crystal structure of PDE10A2 with fragment ZT1597 (2-({[(2S)-2-methyl-2,3-dihydro-1,3-benzothiazol-…monomer715-1041
2ZU;NI;
Assess
crystal structure of PDE10A2 mutant D674A in complex with cGMPmonomer715-1040
MG;35G;
Assess
Novel, potent, selective and brain penetrant phosphodiesterase 10A inhibitorsmonomer715-1040
ZN;MG;JY4;
Assess
Crystal Structure of PDE10A2 with fragment ZT0143 ((2S)-4-chloro-2,3-dihydro-1,3-benzothiazol-2-ami…monomer715-1040
2D0;NI;
Assess
crystal structure of PDE10A2 in complex with GMPmonomer715-1038
ZN;MG;5GP;
Assess
Human PDE-papaverine complex obtained by ligand soaking of cross- linked protein crystalsmonomer713-1036
EV1;ZN;MG;
Assess
crystal structure of PDE10A2 mutant D674Amonomer715-1037
MG;
Assess
PDE10 complexed with 6-chloro-2-cyclopropyl-5-methyl-pyrimidin-4-aminemonomer715-1037
ZN;MG;4XV;
Assess
crystal structure of pde10a2 mutant of D564Nmonomer715-1037
ZN;MG;
Assess
PDE10 complexed with 4,6-dichloro-2-cyclopropyl-5-methyl-pyrimidinemonomer715-1037
ZN;MG;4XS;
Assess
PDE10 complexed with N-[(1-methylpyrazol-4-yl)methyl]-5-[[(1S,2S)-2-(2-pyridyl)cyclopropyl]methoxy]…monomer724-1046
ZN;MG;5AY;
Assess
crystal structure of PDE10A2 mutant D674A in complex with cAMPmonomer715-1036
MG;CMP;
Assess
crystal structure of PDE10Amonomer715-1036
ZN;MG;
Assess
crystal structure of PDE10A2 in complex with AMPmonomer715-1036
ZN;MG;AMP;
Assess
Crystal structure of PDE10A in complex with ASP9436monomer715-1036
ZN;MG;490;
Assess
Crystal structure of PDE10A in complex with inhibitormonomer715-1036
ZN;MG;P98;
Assess
Identification and structural characterization of PDE10 fragment inhibitorsmonomer715-1036
ZN;MG;F04;
Assess
Crystal structure of PDE10A in complex with a triazolopyrimidine inhibitormonomer715-1036
ZN;MG;D6X;
Assess
Crystal structure of PDE10A in complex with a benzimidazole inhibitormonomer715-1036
ZN;MG;X4C;
Assess
Crystal structure of PDE10 in complex with inhibitor 2bmonomer715-1036
ZN;MG;
Assess
Crystal structure of PDE10A catalytic domain complexed with LHB-6monomer715-1036
ZN;MG;9G6;
Assess
Crystal structure of PDE10A in complex with a triazolopyrimidine inhibitormonomer715-1036
ZN;MG;D7C;
Assess
Crystal structure of PDE10A in complex with a benzimdazole inhibitormonomer715-1036
ZN;MG;X4D;
Assess
Crystal structure of PDE10A in complex with a triazolopyrimidine inhibitormonomer715-1036
ZN;MG;D79;
Assess
Crystal structure of PDE10A in complex with 1-methyl-5-(1-methyl-3-{[4-(quinolin-2-yl)phenoxy]methy…monomer715-1036
ZN;MG;3SJ;
Assess
Highly Potent, Selective, and Orally Active Phosphodiestarase 10A Inhibitorsmonomer715-1035
CL;540;ZN;MG;
Assess
Highly Potent, Selective, and Orally Active Phosphodiestarase 10A Inhibitorsmonomer715-1035
ZN;MG;CL;546;
Assess
PDE10 complexed with 6-chloro-2-cyclopropyl-N-[(2,4-dimethylthiazol-5-yl)methyl]-5-methyl-pyrimidin…monomer715-1035
ZN;MG;4Y2;
Assess
Potent and Selective Phosphodiesterase 10A Inhibitorsmonomer715-1035
ZN;MG;0T6;
Assess
Potent and Selective Phosphodiesterase 10A Inhibitorsmonomer715-1035
ZN;MG;0T7;
Assess
PDE10 complexed with6-chloro-N-[(2,4-dimethylthiazol-5-yl)methyl]-5-methyl-2-[2-(2-pyridyl)ethoxy]p…monomer715-1035
ZN;MG;4PX;
Assess
Novel, potent, selective and brain penetrant phosphodiesterase 10A inhibitorsmonomer715-1035
ZN;MG;JY7;
Assess
Highly Potent, Selective, and Orally Active Phosphodiestarase 10A Inhibitorsmonomer715-1035
ZN;MG;
Assess
Crystal structure of PDE10A in complex with 7-(4-chlorophenyl)-2-methylpyrazolo[1,5-a]pyrimidinemonomer715-1035
ZN;MG;8G6;
Assess
Crystal structure of PDE10A in complex with 2-methyl-5-[2-([1,2,4]triazolo[1,5-a]pyrimidin-2-yl)et …monomer715-1035
ZN;MG;8G3;
Assess
Crystal structure of human PDE10A in complex with inhibitor 16dmonomer715-1034
8Q7;ZN;MG;
Assess
Discovery of MK-8189, a highly potent and selective PDE10A inhibitor for the treatment of schizophr…monomer715-1034
ZN;MG;S9I;
Assess
PDE10 complexed with 6-chloro-N-[(2,4-dimethylthiazol-5-yl)methyl]-5-methyl-2-[3-(2-quinolyl)propox…monomer715-1034
ZN;MG;4XU;
Assess
Identification and structural characterization of PDE10 fragment inhibitorsmonomer715-1034
ZN;MG;F07;
Assess
Crystal structure of PDE10 in complex with inhibitor AF-399/14387019monomer715-1034
ZN;MG;AEO;
Assess
Discovery of Lu AF11167, a Phosphodiesterase 10A inhibitor clinical candidatemonomer722-1040
ZN;MG;EFJ;
Assess
PDE10A in complex with the inhibitor AZ5monomer715-1033
ZN;MG;4HN;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 6-cyclopropyl-N-[4-(piperidin-1-ylm…monomer724-1041
ZN;MG;K4U;
Assess
Development of a plate-based optical biosensor methodology to identify PDE10 fragment inhibitorsmonomer715-1032
ZN;MG;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 6-cyclopropyl-N-(3-oxo-1,2-dihydroi…monomer724-1040
ZN;MG;IJ7;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with N-[(E)-(4-bromo-3,5-dimethoxyphenyl…monomer724-1040
ZN;MG;IXT;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 4-N,2-dimethyl-4-N-[2-(methylamino)…monomer725-1040
ZN;MG;JSM;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 4-N-cyclopropyl-2-methyl-3-N-(2-phe…monomer723-1038
ZN;MG;JIC;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 12-methoxy-5,7-dimethyl-3-propyl-2,…monomer724-1039
ZN;MG;Z73;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 5-[(3R)-3-fluoropyrrolidin-1-yl]-2-…monomer723-1038
JU6;ZN;MG;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 3-N-[2-(3-chlorophenyl)-1H-benzimid…monomer724-1039
ZN;MG;IVJ;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with N-[3-[3-[5-(4-fluorophenyl)thieno[2…monomer725-1040
ZN;IYA;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 6-cyclopropyl-N-[1-(2-methoxyethyl)…monomer723-1038
ZN;MG;II5;
Assess
Crystal structure of the catalytic domain of PDE10A complexed with highly potent and brain-penetran…monomer721-1035
MG;ZN;4LP;
Assess
Crystal structure of the catalytic domain of PDE10A complexed with 1-(2-fluoro-4-(2-oxo-1,3-oxazoli…monomer721-1035
MG;ZN;4LK;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 4-chloro-2,5-dimethyl-N-(2-phenylim…monomer724-1038
ZN;MG;K0R;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 4-(2-chloroquinazolin-4-yl)morpholi…monomer724-1038
ZN;MG;JXX;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 1-(3,4-dimethoxyphenyl)-5-ethyl-7,8…monomer724-1038
ZN;MG;JPU;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 6-cyclopropyl-N-[5-(dimethylcarbamo…monomer725-1039
ZN;MG;IB4;
Assess
Discovery of orally active pyrazoloquinoline as a potent PDE10 inhibitor for the management of schi…monomer722-1036
C1L;MG;ZN;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 6-cyclopropyl-N-[3-(dimethylcarbamo…monomer725-1039
ZN;MG;IBV;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 4-chloro-N-(2-phenyl-1H-benzimidazo…monomer724-1038
ZN;MG;KCU;
Assess
Crystal structure of the catalytic domain of human PDE10A complexed with 1-(cyclopropylmethyl)-5-(2…monomer721-1035
MG;ZN;6DW;
Assess
Discovery of Lu AF11167, a Phosphodiesterase 10A inhibitor clinical candidatemonomer721-1035
EEI;ZN;MG;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 3-[2-(3-ethynylphenyl)pyrazol-3-yl]…monomer724-1038
ZN;MG;JK6;
Assess
Crystal structure of the catalytic domain of PDE10A complexed with 5-methoxy-3-(1-phenyl-1H-pyrazol…monomer721-1035
ZN;MG;3KB;
Assess
Crystal structure of the catalytic domain of human PDE10A complexed with N-(4-((5-methyl-5H-pyrrolo…monomer721-1035
MG;ZN;6DT;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 2-methyl-4-(2-methylpyrrolidine-1-c…monomer725-1038
ZN;MG;JQL;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 2-methyl-4-(morpholine-4-carbonyl)-…monomer725-1038
ZN;MG;JKO;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 6-(3-methylphenyl)sulfanyl-2-(4-pyr…monomer723-1036
ZN;MG;GOL;JPF;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 2-ethyl-3-[4-(4-methylphenyl)sulfon…monomer723-1036
ZN;MG;GOL;JRX;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 6-(3-methylphenoxy)-2-(4-pyridin-2-…monomer723-1036
ZN;MG;GOL;IX9;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 4-chloro-2-methyl-N-(2-phenyl-1H-be…monomer723-1036
ZN;MG;K3F;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with [4-(2-methoxyphenyl)piperazin-1-yl]…monomer723-1036
ZN;MG;KI8;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 2-[[4-(1-methyl-4-pyridin-4-ylpyraz…monomer723-1036
ZN;MG;GOL;PF9;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with [1-(4-chlorophenyl)-3-methylthieno[…monomer723-1036
ZN;MG;GOL;JX0;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 3-N-[2-(4-fluorophenyl)imidazo[1,2-…monomer725-1038
ZN;MG;IY2;
Assess
human PDE10A in complex with 1-(4-Chloro-phenyl)-3-methyl-1H-thieno[2,3-c]pyrazole-5-carboxylic aci…monomer723-1036
ZN;MG;GOL;5M6;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 4-bromo-2,5-dimethyl-N-(2-phenylimi…monomer723-1036
ZN;MG;K9X;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 2-[2-[5-[3-(difluoromethyl)pyrrolid…monomer723-1036
ZN;MG;JBV;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 5,7,8-trimethyl-2-[2-(2-methyl-5-py…monomer724-1037
IFR;ZN;MG;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 3-(naphthalen-1-ylmethyl)-7-piperid…monomer723-1036
ZN;MG;GOL;JIS;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with [8-[(2-methyl-1,3-thiazol-4-yl)amin…monomer723-1036
ZN;MG;K;CL;JJR;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 6-cyclopropyl-N-(2-methyl-5-pyridin…monomer725-1038
ZN;MG;IH8;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 1-methyl-5-[(2-phenylimidazo[1,2-a]…monomer724-1037
JLI;ZN;MG;
Assess
Triazoloquinazolines as a novel class of phosphodiesterase 10A (PDE10A) inhibitors, part 2, Lead-op…monomer722-1035
AXC;ZN;MG;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 4-chloro-N-[2-(3,5-dimethylphenyl)-…monomer725-1038
ZN;MG;JQC;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 3-N-[2-(3-fluorophenyl)imidazo[1,2-…monomer724-1036
ZN;MG;WP3;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 2-phenyl-6-(2-phenylpyrazol-3-yl)-3…monomer724-1036
ZN;MG;IZ6;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with N-[3-[3-[2-(2-fluorophenyl)pyrazol-…monomer724-1036
ZN;MG;CL;KHU;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 6-chloro-N,N-dimethyl-2-[2-(1-pyrid…monomer724-1036
ZN;MG;KHI;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 5,8-dimethyl-2-[2-[2-methyl-5-[(2R)…monomer724-1036
ZN;MG;IZH;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 2,3-dimethyl-6-[(1-methyl-4-phenyli…monomer724-1036
ZN;MG;ID9;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 5-[2-(1-methyl-4-phenylimidazol-2-y…monomer724-1036
ZN;MG;K9F;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 4-chloro-2-(2-methylpropyl)-N-(2-ph…monomer724-1036
ZN;MG;CL;GOL;K9O;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 2-methyl-4-(morpholine-4-carbonyl)-…monomer724-1036
ZN;MG;GOL;JKO;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 1-(6-fluoropyridin-2-yl)piperidin-4…monomer724-1036
ZN;MG;JKX;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 4-N-(2-methoxyethyl)-4-N,2-dimethyl…monomer724-1036
ZN;MG;GOL;IYD;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 2,9-dimethyl-6-[(1-methyl-4-phenyli…monomer724-1036
ZN;MG;IEB;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 3-[2-(3-bromophenyl)pyrazol-3-yl]-1…monomer724-1036
ZN;MG;JCJ;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 4-(azetidine-1-carbonyl)-2-methyl-N…monomer724-1036
ZN;MG;ILZ;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 5,8-dimethyl-2-[2-(2-methyl-5-pyrro…monomer724-1036
ZN;MG;IVT;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 4-[1-methyl-6-[(1-methyl-4-phenylim…monomer724-1036
ZN;MG;IX5;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 2-[(4-methoxy-3,5-dimethylpyridin-2…monomer724-1036
ZN;MG;JIY;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with N-[(E)-(4-bromo-3,5-dimethoxyphenyl…monomer724-1036
ZN;MG;IVE;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 2,3-dimethyl-6-[2-(1-methyl-4-pheny…monomer724-1036
ZN;MG;IJH;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 4-[2-(1-methylbenzimidazol-2-yl)eth…monomer724-1036
ZN;MG;J7M;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with N-methyl-6-[(6-methylpyridine-2-car…monomer724-1036
ZN;MG;II9;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 2-chloro-6-ethyl-N-(2-phenyl-[1,2,4…monomer724-1036
ZN;MG;IIU;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 6-methyl-N-(4-methylphenyl)pyrimidi…monomer724-1036
ZN;MG;JSY;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 1-methyl-N-(2-methyl-5-pyridin-2-yl…monomer724-1036
ZN;MG;KII;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 2,3-dichloro-N-(2-phenyl-[1,2,4]tri…monomer724-1036
ZN;MG;JWR;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 6-cyclopropyl-N-(2-phenylpyrazol-3-…monomer724-1036
ZN;MG;IF5;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with N-ethyl-6-(4-fluorophenyl)sulfanyl-…monomer724-1036
ZN;MG;GOL;KIE;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 6-methyl-N-(5-methyl-2-phenylpyrazo…monomer724-1036
J9C;ZN;MG;GOL;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with N-(2-chloropyridin-4-yl)-2-phenylpy…monomer724-1036
ZN;MG;IO4;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 6-methyl-3-(2-phenylpyrazol-3-yl)-1…monomer724-1036
ZN;MG;KBL;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 4-(azetidine-1-carbonyl)-N-(6-cyano…monomer724-1036
ZN;MG;JME;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with N-(6-methylpyridin-2-yl)-5-pyridin-…monomer724-1036
ZN;MG;JH6;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 4-N-(2-hydroxyethyl)-2-methyl-3-N-(…monomer724-1036
ZN;MG;JN6;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 3-[2-(6,8-dichloro-5-methyl-[1,2,4]…monomer724-1036
ZN;MG;JT9;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 6-cyclopropyl-N-[2-(2-hydroxyethyl)…monomer724-1036
ZN;MG;IBJ;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with N-[(3R)-1-(5-chloropyridin-2-yl)pyr…monomer724-1036
ZN;MG;KAU;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 7-(cyclopropylmethoxy)-2-methyl-4-p…monomer724-1036
ZN;MG;KIY;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 4-(azetidine-1-carbonyl)-2-methyl-N…monomer724-1036
ZN;MG;ILS;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 2-methyl-3-[2-(1-pyridin-2-ylpyrrol…monomer724-1036
ZN;MG;IYN;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 1-[(4-methoxyphenyl)methyl]-1-[(4-o…monomer724-1036
ZN;MG;JP0;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 4-(azetidine-1-carbonyl)-2-methyl-N…monomer724-1036
ZN;MG;JRL;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 2-methyl-4-N-(1,3-oxazol-2-ylmethyl…monomer724-1036
ZN;MG;JI8;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 6,7-dimethyl-2-[2-(2-methyl-5-pyrro…monomer724-1036
ZN;MG;IJK;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 2-chloro-6-(cyclopropylamino)-N-(2-…monomer724-1036
ZN;MG;KFI;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 2-[2-(1,4-diphenylimidazol-2-yl)eth…monomer724-1036
ZN;MG;IEX;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with N-(2-acetamido-1,3-benzothiazol-5-y…monomer724-1036
ZN;MG;IQJ;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 6-cyclopropyl-3-(pyrimidin-5-ylamin…monomer724-1036
ZN;MG;IYH;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 4-N-ethyl-3-N-[2-[3-(2-fluoroethoxy…monomer724-1036
ZN;MG;IOI;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 2-chloro-3-[(1-methyl-4-phenylimida…monomer724-1036
ZN;MG;IYK;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 4-(azetidine-1-carbonyl)-2-methyl-N…monomer724-1036
ZN;MG;IG9;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 3-(2-quinolin-4-ylpyrazol-3-yl)-1-[…monomer724-1036
ZN;MG;CL;K1X;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 2-[2-[5-[(3R)-3-fluoropyrrolidin-1-…monomer724-1036
ZN;MG;JAP;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 1-[2-(5-methyl-2-phenyl-1,3-oxazol-…monomer724-1036
ZN;MG;IV4;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 4-pyrrolidin-1-yl-7H-pyrrolo[2,3-d]…monomer724-1036
ZN;MG;JIJ;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 1-(2-chlorophenyl)-8-methoxy-3,4-di…monomer724-1036
ZN;MG;IJN;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 6-cyclopropyl-N-[1-methyl-5-(methyl…monomer724-1036
ZN;MG;IEH;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 2-[2-(2-methyl-5-pyrrolidin-1-yl-1,…monomer724-1036
ZN;MG;IHL;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 2-[(4-chloro-3,5-dimethylpyridin-2-…monomer724-1036
ZN;MG;IX2;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 4-(azetidine-1-carbonyl)-2-methyl-N…monomer724-1036
IWK;ZN;MG;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 4-(azetidine-1-carbonyl)-2-methyl-N…monomer724-1036
ZN;MG;IFI;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 3-[2-(2,2-difluoro-1,3-benzodioxol-…monomer724-1036
ZN;MG;CL;K1I;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 2-benzyl-6,6-dimethyl-1H-imidazo[4,…monomer724-1036
ZN;MG;JML;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 4-N,4-N,2-trimethyl-3-N-(2-phenylim…monomer724-1036
ZN;MG;CL;K5F;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 4-(azetidine-1-carbonyl)-2-methyl-N…monomer724-1036
ZN;MG;IIX;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 6-cyclopropyl-3-methoxy-N-[2-(3-pyr…monomer724-1036
ZN;MG;JWC;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with N-(6-cyano-2-phenylimidazo[1,2-a]py…monomer724-1036
ZN;MG;JMU;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 2-[2-(4-cyclopentyl-1-methylimidazo…monomer724-1036
ZN;MG;IGI;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with (2R)-2-[[3-cyano-2-[4-(2-ethoxyphen…monomer724-1036
K63;ZN;MG;CL;GOL;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 3-[2-(3-fluorophenyl)pyrazol-3-yl]-…monomer724-1036
ZN;MG;CL;KFO;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 2-[2-(5-methyl-2-phenyl-1H-imidazol…monomer724-1036
ZN;MG;IGE;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 4-N-ethyl-5-[3-(trifluoromethyl)phe…monomer724-1036
ZN;MG;GOL;K3O;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 3-methyl-6-[2-(1-methyl-4-phenylimi…monomer724-1036
ZN;MG;IG6;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 3-[5-[1-(2,2-difluoro-1,3-benzodiox…monomer724-1036
ZN;MG;CL;GOL;KF9;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 3-[2-(2,4-difluorophenyl)pyrazol-3-…monomer724-1036
ZN;MG;CL;K79;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 2,3,5-trimethyl-6-[2-(1-methyl-4-ph…monomer724-1036
JG9;ZN;MG;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 5-(cyclopentylmethoxy)pyrimidin-2-a…monomer724-1036
ZN;MG;JQ3;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 4-(azetidine-1-carbonyl)-2-methyl-N…monomer724-1036
ZN;MG;IGZ;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 2-(difluoromethyl)-3-methyl-6-[2-(1…monomer724-1036
IJ0;ZN;MG;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 5-chloro-8-hydroxy-2-methyl-1,4-dih…monomer724-1036
ZN;MG;JOF;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 6-chloro-2,3-dimethylquinoxalinemonomer724-1036
ZN;MG;K6F;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 3-(2-chlorophenyl)-12-methoxy-5-met…monomer724-1036
ZN;MG;JFO;
Assess
5-methyl-2-[2-(2-methyl-5-pyrrolidin-1-yl-1,2,4-triazol-3-yl)ethyl]-8-(trifluoromethyl)-[1,2,4]tria…monomer724-1036
ZN;MG;JTX;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 2-[(E)-2-(4-methyl-6-pyrrolidin-1-y…monomer724-1036
ZN;MG;IWC;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 6-cyclopropyl-N-[5-[(2-hydroxy-2-me…monomer724-1036
ZN;MG;IL9;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with N-(2-tert-butyl-5-methylpyrazol-3-y…monomer724-1036
ZN;MG;JYU;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 4-(azetidine-1-carbonyl)-2-methyl-N…monomer724-1036
ZN;MG;IXL;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 7-[(5-methyl-4-propan-2-yloxypyridi…monomer724-1036
ZN;MG;JY3;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 2-chloro-N-(2-phenyl-[1,2,4]triazol…monomer724-1036
ZN;MG;ICK;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 2-(4-fluorophenyl)-4-(2-isoquinolin…monomer724-1036
ZN;MG;KB6;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 5-methyl-4-[2-(1-methyl-4-phenylimi…monomer724-1036
ZN;MG;I9Z;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 5-ethyl-8-methyl-2-[2-(2-methyl-5-p…monomer724-1036
ZN;MG;IQF;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 3-methylimidazo[4,5-f]quinolin-2-am…monomer724-1036
ZN;MG;GIQ;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 2-methyl-3-N-(2-phenylimidazo[1,2-a…monomer724-1036
ZN;MG;IJA;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 7-[(4-methoxy-3,5-dimethylpyridin-2…monomer724-1036
ZN;MG;JFW;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 2-methyl-3-[2-(1-methyl-4-phenylimi…monomer724-1036
ZN;MG;IFY;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with N-[1-methyl-5-(methylcarbamoyl)pyra…monomer724-1036
ZN;MG;KGO;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 4-(azetidine-1-carbonyl)-2-methyl-N…monomer724-1036
ZN;MG;IJQ;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with [2-methyl-6-[2-(1-methyl-4-phenylim…monomer724-1036
IKH;ZN;MG;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 2-methyl-3-pyrrolidin-1-ylquinoxali…monomer724-1036
ZN;MG;JJF;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 1-[2-(5-methyl-2-phenyl-1,3-oxazol-…monomer724-1036
ZN;MG;IV0;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 2-methyl-4-(morpholine-4-carbonyl)-…monomer724-1036
ZN;MG;ILN;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with N-[(5,8-dimethyl-[1,2,4]triazolo[1,…monomer724-1036
ZN;MG;KFX;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 7-[(3,5-dimethyl-4-propan-2-yloxypy…monomer724-1036
ZN;MG;JWJ;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 5-butoxy-4-ethoxypyrimidin-2-aminemonomer724-1036
ZN;MG;IW9;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 1-[2-(3,5-dimethylpyrazol-1-yl)ethy…monomer724-1036
ZN;MG;K18;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 1-[(4-methoxyphenyl)methyl]-3-(4-me…monomer724-1036
ZN;MG;IVP;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 4-(azetidine-1-carbonyl)-2-methyl-N…monomer724-1036
ZN;MG;IE7;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 2-[(4-methoxy-3,5-dimethylpyridin-2…monomer724-1036
ZN;MG;JIG;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 5,6,8-trimethyl-2-[2-(2-methyl-5-py…monomer724-1036
ZN;MG;IGO;
Assess
Crystal Structure of human phosphodiesterase 10 in complex withmonomer724-1036
ZN;MG;IK6;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with (2-phenyl-[1,2,4]triazolo[1,5-a]pyr…monomer724-1036
ZN;MG;JJ6;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 4-[6-[2-(1-methyl-4-phenylimidazol-…monomer724-1036
ZN;MG;IAY;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 2,3-dimethylquinoxalin-6-aminemonomer724-1036
ZN;MG;JD6;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 2-methyl-4-(morpholine-4-carbonyl)-…monomer724-1036
ZN;MG;KA6;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 4-(azetidine-1-carbonyl)-2-methyl-N…monomer724-1036
ZN;MG;J0O;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 4-(azetidine-1-carbonyl)-N-[3-(1,3-…monomer724-1036
ZN;MG;KC9;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 2-tert-butyl-5-(pyrimidin-5-ylamino…monomer724-1036
ZN;MG;KF3;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 3-[4-[2-[2-(2-ethoxy-4-fluorophenyl…monomer724-1036
ZN;MG;KJ3;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with N-(thiophen-2-ylmethyl)quinoxaline-…monomer724-1036
ZN;MG;JTL;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 2-[2-(1-methyl-4-phenylimidazol-2-y…monomer724-1036
ZN;MG;IBY;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 3-(2-chlorophenyl)-12-methoxy-5-met…monomer724-1036
ZN;MG;IZQ;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 4-(azetidine-1-carbonyl)-2-methyl-N…monomer724-1036
ZN;MG;IG1;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with N-(6-cyano-2-phenylimidazo[1,2-a]py…monomer724-1036
ZN;MG;KH6;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 3-[2-(2,5-difluorophenyl)pyrazol-3-…monomer724-1036
ZN;MG;CL;GOL;JOO;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 2-methyl-4-(2-methylpyrrolidine-1-c…monomer724-1036
ZN;MG;CL;JRC;
Assess
human PDE10A, 6-Chloro-5,8-dimethyl-2-[2-(2-methyl-5-pyrrolidin-1-yl-2H-[1,2,4]triazol-3-yl)-ethyl]…monomer724-1036
ZN;MG;5M9;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 6H-imidazo[1,2-c]quinazolin-5-onemonomer724-1036
ZN;MG;IWS;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 2-[(4-methoxy-3,5-dimethylpyridin-2…monomer724-1036
ZN;MG;K0C;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 5-methyl-2-phenyl-4-(2-quinolin-8-y…monomer724-1036
ZN;MG;IZW;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 4-(azetidine-1-carbonyl)-N-[1-(2,2-…monomer724-1036
ZN;MG;IO7;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 7-[(4-ethoxy-5-methylpyridin-2-yl)m…monomer724-1036
ZN;MG;KDC;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 6-[(5-methoxy-3,4,6-trimethylpyridi…monomer724-1036
ZN;MG;J4I;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 5,8-dichloro-2,3,4,9-tetrahydropyri…monomer724-1036
ZN;MG;K40;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 4-N-(2-fluoroethyl)-4-N,2-dimethyl-…monomer724-1036
ZN;MG;IGW;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 6-cyclopropyl-N-[2-[2-(dimethylamin…monomer724-1036
ZN;MG;IJD;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with ethyl N-[[4-[[4-(azetidine-1-carbon…monomer724-1036
ZN;MG;K6O;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 2-[2-[3-(4-methoxyphenyl)-4-oxoquin…monomer724-1036
ZN;MG;IYS;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with N-[(3R)-1-(5-chloropyridin-2-yl)pyr…monomer724-1036
ZN;MG;JHX;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with N-(12-methoxy-5-methyl-3-propyl-2,4…monomer724-1036
ZN;MG;JM0;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 8-chloro-5,7-dimethyl-2-[2-(2-methy…monomer724-1036
ZN;MG;JIV;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 7-methyl-2,5-bis[2-(1-methyl-5-pyrr…monomer724-1036
ZN;MG;JKD;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 1-(2,3-dimethylquinoxalin-6-yl)-3-(…monomer724-1036
ZN;MG;JNL;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 3,6-dimethyl-N-(2-phenylpyrazolo[1,…monomer724-1036
ZN;MG;JFG;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 2-methyl-3-[2-(2-methyl-5-pyrrolidi…monomer724-1036
ZN;MG;IF2;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with N-cyclopropyl-5-[2-(5,8-dimethyl-[1…monomer724-1036
ZN;MG;IKO;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 7-bromo-N,N-dimethyl-[1,2,4]triazol…monomer724-1036
ZN;MG;KCF;BR;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with N-(1,3-dimethyl-2-oxobenzimidazol-5…monomer724-1036
ZN;MG;IZT;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 6-[(5-bromo-1-methyl-2-oxopyridine-…monomer724-1036
ZN;MG;IFN;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with [2-cyclopropyl-6-[2-(1-methyl-4-phe…monomer724-1036
ZN;MG;IIR;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 2-amino-4-cyclohexyloxyquinoline-3-…monomer724-1036
ZN;MG;J6I;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with ethyl 1-methyl-5-(propylcarbamoyl)p…monomer724-1036
ZN;MG;IWY;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 4-(azetidine-1-carbonyl)-2-methyl-N…monomer724-1036
ZN;MG;JGI;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 3-(2-phenylethyl)-5-pyridin-4-yl-1H…monomer724-1036
ZN;MG;K4L;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 4-N,2-dimethyl-3-N-(2-phenylimidazo…monomer724-1036
ZN;CL;MG;IKE;
Assess
human PDE10A in complex with 3-(2-Chloro-5-phenyl-3H-imidazol-4-yl)-1-(3-trifluoromethoxy-phenyl)-1…monomer724-1036
ZN;MG;5MG;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 3-[2-(2,5-difluorophenyl)pyrazol-3-…monomer724-1036
ZN;MG;KER;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 2,3,5-trimethyl-6-[2-(1-methyl-4-ph…monomer724-1036
ZN;MG;IHV;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with N-[(3R)-1-(5-chloropyridin-2-yl)pyr…monomer724-1036
ZN;MG;IKK;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 5,8-dimethyl-2-[2-(1-methyl-5-pyrro…monomer724-1036
IOZ;ZN;MG;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 4-[6-chloro-2-[(1-methyl-4-phenylim…monomer724-1036
ZN;MG;IEU;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 6-cyclopropyl-3-[(1-methyl-4-phenyl…monomer724-1036
ZN;MG;IJW;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with [2-cyclopropyl-6-[2-(1-methyl-4-phe…monomer724-1036
IIR;ZN;MG;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 6-cyclopropyl-3-(pyrimidin-5-ylamin…monomer724-1036
ZN;MG;IL6;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 1-[2-(5-methyl-2-phenyl-1,3-oxazol-…monomer724-1036
ZN;MG;JDU;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with N-cyclohexyl-N-methyl-9H-purin-6-am…monomer724-1036
ZN;MG;JX9;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 6-cyclopropyl-N-[3-[2,3-dihydroxypr…monomer724-1036
ZN;MG;IB7;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 6-chloro-2,3-dimethyl-8-pyrrolidin-…monomer724-1036
ZN;MG;JHI;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 6-cyclopropyl-N-(2-pyridin-2-ylpyra…monomer724-1036
ZN;MG;CL;IEN;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 9-methoxy-3,5-dihydropyrimido[5,4-b…monomer724-1036
ZN;MG;KDX;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 4-N,4-N,2-trimethyl-3-N-(2-phenyl-1…monomer724-1036
ZN;MG;IAL;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 4-chloro-2-(2-methylpropyl)-N-(2-ph…monomer724-1036
ZN;MG;IZK;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 2-methyl-3-[(1-methyl-4-phenylimida…monomer724-1036
ZN;MG;IJT;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 6-chloro-2-[(E)-2-(2-methyl-5-pyrro…monomer724-1036
IFE;ZN;MG;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 5-(4-chloronaphthalen-1-yl)oxythiad…monomer724-1036
ZN;MG;IWG;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 3-(2-naphthalen-1-ylpyrazol-3-yl)-1…monomer724-1036
ZN;MG;JLR;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with N-[2-(1-methyl-4-phenylimidazol-2-y…monomer724-1036
ZN;MG;JYL;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 6-cyclopropyl-3-(pyrimidin-5-ylamin…monomer724-1036
ZN;MG;IQ3;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with N-(3-methyl-1-pyridin-2-ylthieno[2,…monomer724-1036
ZN;MG;JQU;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 6-cyclopropyl-N-(1-pyridin-2-ylpyrr…monomer724-1036
ZN;MG;JL6;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 4-(azetidine-1-carbonyl)-N-(1-cyclo…monomer724-1036
ZN;MG;IQ9;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 2-methyl-3-N-(2-phenylimidazo[1,2-a…monomer724-1036
ZN;MG;IKZ;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 2-[2-(2-methyl-5-pyrrolidin-1-yl-1,…monomer724-1036
ZN;MG;IV8;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 6-chloro-2-[2-(2-methyl-5-pyrrolidi…monomer724-1036
ZN;MG;IFV;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 6-chloroquinoxalin-2-aminemonomer724-1036
ZN;MG;JXO;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 12-methoxy-5-methyl-3-propyl-2,4,8,…monomer724-1036
ZN;MG;JYA;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 3,6-dimethyl-N-(2-phenylimidazo[1,2…monomer724-1036
ZN;MG;JSF;
Assess
human PDE10A in complex with 3-(2-phenylpyrazol-3-yl)-1-[3-(trifluoromethoxy)phenyl]pyridazin-4-onemonomer724-1036
ZN;MG;67A;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 3-methyl-6-[2-(2-methyl-5-pyrrolidi…monomer724-1036
ZN;MG;JNU;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 4-(methoxymethyl)-2-methyl-N-(2-phe…monomer724-1036
ZN;MG;IWN;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 5,8-dimethyl-2-[2-(1-methyl-4-pheny…monomer724-1036
ZN;MG;EIK;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 6-cyclopropyl-N-[3-[(2-hydroxy-2-me…monomer724-1036
ZN;MG;KJC;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 6-methyl-N-(1-propan-2-ylpyrazol-3-…monomer724-1036
ZN;MG;KE6;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 6-cyclopropyl-N-[4-(methylcarbamoyl…monomer724-1036
ZN;MG;JCP;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 6-cyclopropyl-N-[4-[(2-hydroxy-2-me…monomer724-1036
ZN;MG;K49;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 6-[(5-cyclopropyl-2-oxo-1H-pyridine…monomer724-1036
ZN;MG;J8J;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 6-[(3,6-dimethylpyridine-2-carbonyl…monomer724-1036
ZN;MG;IXI;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 6-cyclopropyl-N-[4-(dimethylcarbamo…monomer724-1036
ZN;CL;MG;K5R;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 6-cyclopropyl-N-[2-[2-(methylamino)…monomer724-1036
ZN;MG;KG3;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 1-methyl-6-[2-(1-methyl-4-phenylimi…monomer724-1036
ZN;MG;JXI;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 2-chloro-5-methoxy-3-methylquinoxal…monomer724-1036
ZN;MG;KD4;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 1-[2-[2-(5,8-dimethyl-[1,2,4]triazo…monomer725-1036
ZN;MG;K2L;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 2,3-dimethyl-6-[2-(2-methyl-5-pyrro…monomer725-1036
ZN;MG;J2L;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with N,2,3-trimethyl-6-[2-(2-methyl-5-py…monomer725-1036
ZN;MG;IK0;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with N-[(5,8-dimethyl-[1,2,4]triazolo[1,…monomer725-1036
ZN;MG;JIP;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 5-chloro-2-[2-(6,8-dichloro-5-methy…monomer725-1036
ZN;MG;JO6;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 4-(azetidine-1-carbonyl)-2-methyl-N…monomer725-1036
ZN;MG;IE1;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 1-benzyl-3-(2-phenylpyrazol-3-yl)py…monomer725-1036
ZN;MG;GOL;IYW;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 5,8-dimethyl-2-[2-[2-methyl-5-(2-me…monomer725-1036
ZN;MG;IKU;
Assess
human PDE10A, 8-ethyl-5-methyl-2-[2-(2-methyl-5-pyrrolidin-1-yl-1,2,4-triazol-3-yl)ethyl]-[1,2,4]tr…monomer725-1036
ZN;MG;5MF;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 5-[(3R)-3-fluoropyrrolidin-1-yl]-N-…monomer725-1036
ZN;MG;JUC;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 6,8-dichloro-2-[2-(6,7-dimethyl-1H-…monomer725-1036
ZN;MG;K7O;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 5,8-dimethyl-2-[2-(2-methyl-5-piper…monomer725-1036
ZN;MG;IKB;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 2,3-dimethyl-6-[2-(2-methyl-5-pyrro…monomer725-1036
ZN;MG;IY6;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 5,8-dimethyl-2-[(E)-2-[2-methyl-5-(…monomer725-1036
ZN;MG;IQV;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with N-(3-imidazo[1,2-a]pyridin-2-ylphen…monomer725-1036
ZN;MG;CL;KI4;
Assess
Discovery of Lu AF11167, a Phosphodiesterase 10A inhibitor clinical candidatemonomer724-1035
ZN;MG;EIH;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 5,8-dimethyl-2-[2-[2-methyl-5-[(3S)…monomer725-1036
ZN;MG;IOU;
Assess
Discovery of Lu AF11167, a Phosphodiesterase 10A inhibitor clinical candidatemonomer724-1035
ZN;MG;EHI;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with ethyl 1-[3-[3-(4-ethoxycarbonyl-5-m…monomer725-1036
ZN;MG;KIS;
Assess
The crystal structue of PDE10A complexed with 14monomer724-1035
ZN;MG;DZU;
Assess
Discovery of Lu AF11167, a Phosphodiesterase 10A inhibitor clinical candidatemonomer724-1035
EIK;ZN;MG;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 5-cyclopropyl-7-methyl-2-[2-(1-meth…monomer725-1036
ZN;MG;ICW;
Assess
Discovery of a potent, selective and orally active PDE10A inhibitor for the treatment of schizophre…monomer724-1035
LKF;ZN;MG;
Assess
PDE10a with imidazopyrazine inhibitormonomer724-1035
ZN;MG;6RC;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 2-methyl-4-N-(1,3-oxazol-4-ylmethyl…monomer726-1036
ZN;MG;IAI;
Assess
Crystal Structure of human phosphodiesterase 10 in complex with 3-[2-(2-fluorophenyl)pyrazol-3-yl]-…monomer725-1035
IVY;ZN;MG;
Assess
Crystal Structure of human phosphodiesterase 10monomer725-1034
ZN;MG;
Assess
The crystal structue of PDE10A complexed with 2dmonomer726-1035
ZN;MG;DL0;
Assess
The crystal structue of PDE10A complexed with 1imonomer728-1035
DKU;ZN;MG;
Assess
PDE10 complexed with 6-chloro-2-cyclopropyl-5-methyl-N-propyl-pyrimidin-4-aminemonomer730-1036
ZN;MG;4XY;
Assess
The SAR development of dihydroimidazoisoquinoline derivatives as phosphodiesterase 10A inhibitors f…monomer729-1035
MG;ZN;
Assess
PDE10 complexed with 5-chloro-N-[(2,4-dimethylthiazol-5-yl)methyl]pyrazolo[1,5-a]pyrimidin-7-aminemonomer727-1033
ZN;MG;5AV;4PX;
Assess
The crystal structue of PDE10A complexed with 4dmonomer729-1034
DZU;ZN;MG;
Assess
The discovery of potent, selectivity, and orally bioavailable pyrozoloquinolines as PDE10 inhibitor…monomer731-1035
0CV;MG;ZN;PO4;
Assess

2 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
3ibj.1.Amonomer0.66365-1033
ZN;MG;31.80
Assess
8ulg.1.Amonomer0.64291-1037
ZN;IBM;25.37
Assess

4 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 13ibj.1.Amonomer0.6574-757
ZN;MG;31.32
Assess
Isoform 18ugb.1.Amonomer0.6417-760
ZN;25.54
Assess
Isoform 23ibj.1.Amonomer0.6584-767
ZN;MG;31.32
Assess
Isoform 28ugb.1.Amonomer0.6427-770
ZN;25.54
Assess